IGHE and atopic eczema: This could potentially lead to excessive production of Th2- and Th2-related signaling molecules, activation of B cells and the production of IgE, eosinophilia, and the release of downstream inflammatory mediators and the induction of clinical symptoms of atopic dermatitis [43].